Director Graziano Angelo Giovanni Pasquino DeLucchi filed a Form 4 with the SEC on November 4, 2026, disclosing the grant of 10,000 stock options in U.S. GoldMining Inc. (NASDAQ:USGO) on November 2, 2026.

Key Highlights

  • Reporting person: Graziano Angelo Giovanni Pasquino DeLucchi, identified as a Director of U.S. GoldMining Inc.
  • Grant date: November 2, 2026, with 10,000 stock options acquired (transaction code A).
  • Exercise price: $5.71 per option, with an expiration date of November 2, 2031.
  • Vesting schedule: Four equal installments of 25% each, beginning November 2, 2026, then May 2, 2027, November 2, 2027, and May 2, 2028.
  • Beneficial ownership following transaction: 10,000 derivative securities (stock options), held directly.
  • Underlying security: Common Stock of U.S. GoldMining Inc., with 10,000 shares underlying the options.

DeLucchi Stock Option Grant Details: November 2, 2026 Award

According to the Form 4 filing, Director Graziano Angelo Giovanni Pasquino DeLucchi received a grant of 10,000 stock options in U.S. GoldMining Inc. (NASDAQ:USGO) on November 2, 2026. The options carry an exercise price of $5.71 and are exercisable into common stock of the company. The options are set to expire on November 2, 2031, giving a five-year window from the grant date.

The filing discloses that the options vest in four equal installments. Per the explanation of responses included in the filing, 25% vested immediately on November 2, 2026, with subsequent tranches vesting on May 2, 2027, November 2, 2027, and May 2, 2028. Following the reported transaction, the filing states that DeLucchi beneficially owns 10,000 derivative securities, held directly.

DeLucchi's address is listed as 1830 - 1188 W. Georgia Street, Vancouver, British Columbia, Canada. The form was filed on November 4, 2026, and was signed by Graziano Angelo Giovanni Pasquino DeLucchi on that same date. No non-derivative securities transactions were reported in Table I of the filing.

What Was Disclosed

The filing reports a single grant of 10,000 stock options to Director DeLucchi at an exercise price of $5.71, vesting over four equal installments between November 2, 2026, and May 2, 2028, with the options expiring November 2, 2031.